Particle.news
Download on the App Store
3 ARTICLES
·
21h ago

Amgen Unveils $600 Million Thousand Oaks Center as Gilead Breaks Ground on $847 Million Foster City Hub

The twin projects are pitched as pillars for California’s life-sciences engine, boosting resilience through automation, predictive analytics, upgraded cold-chain logistics.

Amgen, a Thousand Oaks-based biotechnology giant, plans to invest $600 million in a center for science and innovation at its global headquarters, as seen above on Dec. 12, 2022.(AP Photo/Mark J. Terrill, File)
Image
Image

Overview

  • Amgen will invest $600 million in a science and innovation center at its Thousand Oaks headquarters, with construction expected to begin this month.
  • Gilead has broken ground on a pharmaceutical development and manufacturing center as part of an $847 million expansion of its Foster City campus.
  • State projections indicate the facilities could support nearly 2,500 jobs and contribute about $227 million to annual GDP when fully operational in 2029.
  • Company statements and state briefings emphasize integrated R&D with automation, data-driven operations and advanced cold-chain capabilities to accelerate drug development and strengthen supply chains.
  • California’s life-sciences sector produced $396 billion in 2024 economic output and supports more than 1.15 million jobs, as Amgen reports investing over $40 billion in manufacturing and R&D since 2017.